Cargando…
NOL4 is Downregulated and Hyper-Methylated in Papillary Thyroid Carcinoma Suggesting Its Role as a Tumor Suppressor Gene
BACKGROUND: Thyroid cancer is the fourth most common cancer in the world. Papillary thyroid carcinoma (PTC) accounts for 80% of all types of thyroid neoplasm. Epigenetic alterations such as DNA methylation are known as the main cause of different types of cancers through inactivation of tumor suppre...
Autores principales: | Sheikholeslami, Sara, Azizi, Fereidoun, Ghasemi, Asghar, Alibakhshi, Abbas, Parsa, Hossein, Tavangar, Seyed Mohammad, Shivaee, Setareh, Zarif Yeganeh, Marjan, Hedayati, Mehdi, Teimoori-Toolabi, Ladan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887463/ https://www.ncbi.nlm.nih.gov/pubmed/33613681 http://dx.doi.org/10.5812/ijem.108510 |
Ejemplares similares
-
The Epigenetic Modification of SLC5A8 in Papillary Thyroid Carcinoma and its Effects on Clinic-Pathological Features
por: Sheikholeslami, Sara, et al.
Publicado: (2022) -
Promoter Methylation of Tumor Suppressors in Thyroid Carcinoma: A Systematic Review
por: Sheikholeslami, Sara, et al.
Publicado: (2021) -
Biochemical Assessment: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Hedayati, Mehdi, et al.
Publicado: (2018) -
CRISPR/Cas9 RET Gene Knockout in Medullary Thyroid Carcinoma Cell-lines: Optimization and Validation
por: Zarif-Yeganeh, Marjan, et al.
Publicado: (2022) -
Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer
por: Khatami, Fatemeh, et al.
Publicado: (2017)